Hypertriglyceridemia influences the degree of postprandial lipemic response in patients with metabolic syndrome and coronary artery disease: From the cordioprev study

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Alcala Diaz, Juan F ^a,b   Delgado Lista, Javier ^a,b   Perez Martinez, Pablo ^a,b   Garcia Rios, Antonio ^a,b   Marin, Carmen ^a,b   Quintana Navarro, Gracia M ^a   Gomez Luna, Purificacion ^a,b   Camargo, Antonio ^a,b   Almaden, Yolanda ^a,b   Caballero, Javier ^a   Tinahones, Francisco J ^c   Ordovas, Jose M ^d,e   Perez Jimenez, Francisco ^a,b   Lopez Miranda, Jose ^a,b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d TUFTS UNIVERSITY   (United States)

^e IMDEA FOOD INSTITUTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET RESTRICTION; DISEASE ASSOCIATION; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OUTCOME ASSESSMENT; POSTPRANDIAL STATE; SYNDROME DELINEATION; WAIST CIRCUMFERENCE; AGED; BLOOD; COMPLICATION; CONTROLLED CLINICAL TRIAL; METABOLISM;

ADULT; AGED; CORONARY ARTERY DISEASE; FASTING; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 84900407381     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096297     Document Type: Article

References (40)

1. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG (2008) Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 300: 2142-2152.
2. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, et al. (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298: 309-316. (Pubitemid 47080485)
3. Langsted A, Freiberg JJ, Nordestgaard BG (2008) Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 118: 2047-2056.
4. Nordestgaard BG, Freiberg JJ (2011) Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol. Curr Vasc Pharmacol 9: 281-286.
5. Lupattelli G, Pasqualini L, Siepi D, Marchesi S, Pirro M, et al. (2002) Increased postprandial lipemia in patients with normolipemic peripheral arterial disease. Am Heart J 143: 733-738. (Pubitemid 34454709)
6. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, et al. (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12: 1336-1345.
7. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Iraklianou SA, et al. (2005) Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids Health Dis 4: 21.
8. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Hoursalas IS, et al. (2006) Postprandial lipaemia in menopausal women with metabolic syndrome. Maturitas 55: 19-26. (Pubitemid 44093923)
9. Miller M, Zhan M, Georgopoulos A (2003) Effect of desirable fasting triglycerides on the postprandial response to dietary fat. J Investig Med 51: 50-55. (Pubitemid 36297111)
10. Ntyintyane LM, Panz VR, Raal FJ, Gill GV (2008) Postprandial lipaemia, metabolic syndrome and LDL particle size in urbanised South African blacks with and without coronary artery disease. QJM 101: 111-119. (Pubitemid 351234711)
11. Lopez-Miranda J, Williams C, Lairon D (2007) Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 98: 458-473. (Pubitemid 47272862)
12. Klop B, Proctor SD, Mamo JC, Botham KM, Castro Cabezas M (2012) Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases. Int J Vasc Med 2012: 947417.
13. Lairon D, Defoort C (2011) Effects of nutrients on postprandial lipemia. Curr Vasc Pharmacol 9: 309-312.
14. Grundy SM, Brewer HB Jr., Cleeman JI, Smith SC Jr., Lenfant C (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433-438. (Pubitemid 38133916)
15. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, et al. (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56: 1113-1132.
16. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, et al. (2007) Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49: 403-414. (Pubitemid 46135879)
17. Teramura M, Emoto M, Araki T, Yokoyama H, Motoyama K, et al. (2007) Clinical impact of metabolic syndrome by modified NCEP-ATPIII criteria on carotid atherosclerosis in Japanese adults. J Atheroscler Thromb 14: 172-178.
18. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716. (Pubitemid 35403784)
19. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, et al. (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108: 414-419. (Pubitemid 36935533)
20. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, et al. (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110: 1245-1250. (Pubitemid 39202340)
21. Mente A, Yusuf S, Islam S, McQueen MJ, Tanomsup S, et al. (2010) Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. J Am Coll Cardiol 55: 2390-2398.
22. Jackson KG, Poppitt SD, Minihane AM (2012) Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants. Atherosclerosis 220: 22-33.
23. Mihas C, Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, et al. (2011) Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. Curr Vasc Pharmacol 9: 271-280.
24. Delgado-Lista J, Perez-Martinez P, Perez-Jimenez F, Garcia-Rios A, Fuentes F, et al. (2010) ABCA1 gene variants regulate postprandial lipid metabolism in healthy men. Arterioscler Thromb Vasc Biol 30: 1051-1057.
25. Jackson KG, Walden CM, Murray P, Smith AM, Lovegrove JA, et al. (2012) A sequential two meal challenge reveals abnormalities in postprandial TAG but not glucose in men with increasing numbers of metabolic syndrome components. Atherosclerosis 220: 237-243.
26. Alipour A, Elte JW, van Zaanen HC, Rietveld AP, Castro Cabezas M (2008) Novel aspects of postprandial lipemia in relation to atherosclerosis. Atheroscler Suppl 9: 39-44.
27. O'Keefe JH, Bell DS (2007) Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 100: 899-904.
28. van Wijk JP, Halkes CJ, Erkelens DW, Castro Cabezas M (2003) Fasting and daylong triglycerides in obesity with and without type 2 diabetes. Metabolism 52: 1043-1049.
29. Halkes CJ, Castro Cabezas M, van Wijk JP, Erkelens DW (2001) Gender differences in diurnal triglyceridemia in lean and overweight subjects. Int J Obes Relat Metab Disord 25: 1767-1774. (Pubitemid 33131916)
30. Castro Cabezas M, Erkelens DW, Kock LA, De Bruin TW (1994) Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides. Eur J Clin Invest 24: 669-678. (Pubitemid 24312523)
31. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, et al. (1991) Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11: 653-662.
32. Zilversmit DB (1979) Atherogenesis: a postprandial phenomenon. Circulation 60: 473-485.
33. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A (1994) Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106: 83-97.
34. van Oostrom AJ, Sijmonsma TP, Verseyden C, Jansen EH, de Koning EJ, et al. (2003) Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res 44: 576-583.
35. Alipour A, Elte JW, van Zaanen HC, Rietveld AP, Cabezas MC (2007) Postprandial inflammation and endothelial dysfuction. Biochem Soc Trans 35: 466-469. (Pubitemid 46975053)
36. Bravo E, Napolitano M (2007) Mechanisms involved in chylomicron remnant lipid uptake by macrophages. Biochem Soc Trans 35: 459-463. (Pubitemid 46975051)
37. Skalicky J, Muzakova V, Kandar R, Meloun M, Rousar T, et al. (2008) Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin Chem Lab Med 46: 499-505. (Pubitemid 351820355)
38. Yubero-Serrano EM, Delgado-Lista J, Pena-Orihuela P, Perez-Martinez P, Fuentes F, et al. (2013) Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study. Exp Mol Med 45: e28.
39. Grundy SM (2006) Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Clin Cornerstone 8 Suppl 1: S21-27.
40. O'Meara NM, Lewis GF, Cabana VG, Iverius PH, Getz GS, et al. (1992) Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. J Clin Endocrinol Metab 75: 465-471.